The cardiovascular polypill as baseline treatment improves lipid profile and blood pressure regardless of body mass index in patients with cardiovascular disease. The Bacus study

BACKGROUND: Pharmacological treatment with lipid-lowering and antihypertensive drugs has been proposed as a strategy to improve excess cardiovascular (CV) risk among obese individuals. The present study aimed to assess whether the CV polypill (Sincronium(®)) could be an effective strategy to help im...

Descripción completa

Detalles Bibliográficos
Autores principales: Chávez Fernández, José Alejandro, Ramírez Mendoza, Marcelo, Kassck Ipinaa, Hermelinda, Sánchez Ángeles, Luís Antonio, González Chávez, Antonio, Escobedo, Galileo, Méndez-García, Lucía Angélica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456133/
https://www.ncbi.nlm.nih.gov/pubmed/37624820
http://dx.doi.org/10.1371/journal.pone.0290544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456133/
https://www.ncbi.nlm.nih.gov/pubmed/37624820
http://dx.doi.org/10.1371/journal.pone.0290544

Ejemplares similares